The first edition of the Medical Biotechnology conference took place on 24-25 May in the historic city of Ghent, to be precise in the beautiful venue of the Aula of the Ghent University. The conference covered a wide range of topics such as diagnostics & biomarkers, targeted delivery, biopharmaceutical technology and vaccines.
On day one we kicked-off the conference with an impressive talk from keynote speaker Michael Snyder from the Center for Genomics and Personalized Medicine at Stanford University, US, with his findings that demonstrated that we can use omics profiling to manage our health.
After a day of networking, connecting with peers and reviewing poster abstracts, there was a boat tour to see the sights of the city. There was some rain, but that could not dampen the mood. We finished the day in style with a lovely conference dinner at restaurant Lof.
Day two of the conference was opened by keynote Carl June, from the Perelman School of Medicine at the University of Pennsylvania, US, who told us that CAR T cells have proven that engineered immune cells can serve as cancer therapeutics.
Last but not least we had keynote Gary Nabel, CSO and head of the North American Hub for Global R&D at Sanofi, talking about their engineering of trispecific antibodies, that exhibited a higher potency and breadth then previously single antibodies.
In short, a great opportunity to meet with expert scientist for further discussion and networking!
Some reactions of the attendees:
“This was a great meeting with an exceptional line up of speakers - it is very rare to get that much quality time with people like Gary Nabel or Carl June. Also, the lecture hall is just beautiful.”
“The conference was excellent for networking.”
We hope to see you at the next edition!